The TEDDY study primarily investigated dietary factors, focusing on dietary fiber intake rather than supplements, in relation to celiac disease risk among genetically predisposed children. It followed 6,520 children with HLA-DQ2 or DQ8 haplotypes from birth to age 13, analyzing dietary patterns and their impact on celiac disease development.
The TEDDY study primarily investigated dietary factors, focusing on dietary fiber intake rather than supplements, in relation to celiac disease risk among genetically predisposed children. It followed 6,520 children with HLA-DQ2 or DQ8 haplotypes from birth to age 13, analyzing dietary patterns and their impact on celiac disease development. A key finding was that higher dietary fiber intake during infancy (ages 6 months to 2 years) significantly reduced the risk of developing celiac disease later in life, independent of gluten consumption or specific food sources. This protective effect was limited to early childhood, as fiber intake after age 3 showed no significant association with celiac disease risk.
The study highlighted the importance of dietary fiber in enhancing gut barrier integrity, supporting beneficial microbial colonization, and modulating immune tolerance during critical early-life windows. While maternal fiber intake during pregnancy may also play a role, the infant’s diet emerged as the dominant factor in reducing celiac risk. Foods rich in plant-based fiber, such as oats, legumes, and root vegetables, were associated with lower celiac autoimmunity.
Dietary supplements were not explicitly studied as part of the TEDDY research, but the findings suggest that promoting fiber-rich diets in infancy could serve as a non-invasive preventive strategy for children genetically at risk. Future research could explore whether specific fiber supplements or prebiotics might replicate these protective effects, though current evidence emphasizes whole food sources. Additionally, further mechanistic studies are needed to confirm causality and understand fiber-driven microbial and immune interactions in preventing celiac disease.
Introduction: Anal squamous cell carcinoma is an increasingly common but largely preventable cancer. Most cases arise from persistent high-risk human papillomavirus (HPV) infection, progressing through high-grade squamous intraepithelial lesions (HSIL). This comprehensive review summarizes the...
Introduction: Acute infectious gastroenteritis can trigger persistent gastrointestinal symptoms long after the infection has resolved, leading to post-infection disorders of gut-brain interaction (PI-DGBI). This global Rome Foundation study evaluated the prevalence, risk factors, and clinical...
Introduction: Gut microbiota alterations have been implicated in the pathogenesis of irritable bowel syndrome (IBS), making fecal microbiota transplantation (FMT) a promising therapeutic strategy. However, clinical trials have reported conflicting results. This updated meta-analysis evaluated...
Introduction: Laparoscopic adhesiolysis offers several short-term advantages over open surgery for adhesive small bowel obstruction (ASBO). However, its long-term impact on recurrence, quality of life, and incisional hernia remains uncertain. The LASSO trial provides the...
Introduction: Growing evidence suggests that Parkinson's disease (PD) may originate in the gut, with pathological α-synuclein spreading to the brain through the vagus nerve. This study investigated whether sitagliptin, a widely used DPP-4 inhibitor for...
Introduction: Necrotizing enterocolitis (NEC) is one of the most serious gastrointestinal emergencies in neonates. Early identification of infants requiring surgical intervention is critical but remains challenging. This study compared bedside abdominal ultrasonography (US) with abdominal...
We are pioneers in clinical intelligence, dedicated to helping gastroenterologists harness the power of artificial intelligence to drive precision, efficiency, and patient growth.